Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $RNXT
RenovoRx Inc.
Subscribe to $RNXT
$RNXT
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year: 2021
Exchange: NASDAQ
Recent Analyst Ratings for RenovoRx Inc.
Date
Price Target
Rating
Analyst
11/1/2021
$16.00
Buy
Roth Capital
10/6/2021
$15.00
Buy
Maxim Group
See more ratings
